|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 579.20 DKK | +0.49% |
|
-3.63% | -18.15% |
| 04/06 | Kavaljer Quality Focus rose 7.2 percent in May - bid for Nilörngruppen | FW |
| 22/05 | DNB Carnegie raises Pandora price target to DKK 750 (740), reiterates Buy | FW |
| Fiscal Period: December | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
Profitability | ||||||||||
Return on Assets | 18.27 | 20.78 | 19.2 | 19.33 | 17.08 | |||||
Return on Total Capital | 28.87 | 32.82 | 28.13 | 28.13 | 24.98 | |||||
Return On Equity % | 57.82 | 70.99 | 75.71 | 96.23 | 97.15 | |||||
Return on Common Equity | 57.82 | 70.99 | 75.71 | 96.23 | 97.15 | |||||
Margin Analysis | ||||||||||
Gross Profit Margin % | 76.1 | 76.3 | 78.63 | 79.83 | 79.27 | |||||
SG&A Margin | 52.03 | 50.81 | 53.62 | 54.66 | 55.19 | |||||
EBITDA Margin % | 27.63 | 28.73 | 28.27 | 28.36 | 27.52 | |||||
EBITA Margin % | 25.14 | 26.6 | 26.09 | 26.05 | 24.79 | |||||
EBIT Margin % | 24.07 | 25.48 | 25.01 | 25.17 | 24.08 | |||||
Income From Continuing Operations Margin % | 17.78 | 19 | 16.85 | 16.5 | 16.1 | |||||
Net Income Margin % | 17.78 | 19 | 16.85 | 16.5 | 16.1 | |||||
Net Avail. For Common Margin % | 17.78 | 19 | 16.85 | 16.5 | 16.1 | |||||
Normalized Net Income Margin | 13.81 | 15.43 | 13.85 | 13.66 | 13.38 | |||||
Levered Free Cash Flow Margin | 22.81 | 9.7 | 17.52 | 20.76 | 9.57 | |||||
Unlevered Free Cash Flow Margin | 23.17 | 10.31 | 18.95 | 22.34 | 11.2 | |||||
Asset Turnover | ||||||||||
Asset Turnover | 1.21 | 1.31 | 1.23 | 1.23 | 1.13 | |||||
Fixed Assets Turnover | 4.97 | 5.54 | 4.8 | 4.22 | 3.69 | |||||
Receivables Turnover (Average Receivables) | 24.9 | 23.31 | 21.61 | 23.42 | 25.6 | |||||
Inventory Turnover (Average Inventory) | 2.26 | 1.74 | 1.44 | 1.49 | 1.45 | |||||
Short Term Liquidity | ||||||||||
Current Ratio | 0.73 | 0.69 | 0.99 | 0.93 | 0.91 | |||||
Quick Ratio | 0.35 | 0.29 | 0.46 | 0.47 | 0.32 | |||||
Operating Cash Flow to Current Liabilities | 0.76 | 0.4 | 0.92 | 0.88 | 0.65 | |||||
Days Sales Outstanding (Average Receivables) | 14.66 | 15.66 | 16.89 | 15.63 | 14.26 | |||||
Days Outstanding Inventory (Average Inventory) | 161.28 | 209.53 | 254.29 | 246.02 | 251.76 | |||||
Average Days Payable Outstanding | 178.26 | 155.83 | 193.97 | 195.49 | 215.73 | |||||
Cash Conversion Cycle (Average Days) | -2.33 | 69.36 | 77.21 | 66.16 | 50.29 | |||||
Long Term Solvency | ||||||||||
Total Debt/Equity | 56.08 | 105.87 | 208.53 | 243.3 | 284.44 | |||||
Total Debt / Total Capital | 35.93 | 51.43 | 67.59 | 70.87 | 73.99 | |||||
LT Debt/Equity | 39.49 | 43.67 | 181.83 | 211.06 | 225.71 | |||||
Long-Term Debt / Total Capital | 25.3 | 21.21 | 58.93 | 61.48 | 58.71 | |||||
Total Liabilities / Total Assets | 62.24 | 67.44 | 77.5 | 80.16 | 82.16 | |||||
EBIT / Interest Expense | 42.34 | 25.74 | 10.93 | 9.96 | 9.26 | |||||
EBITDA / Interest Expense | 56.73 | 33.27 | 14.16 | 12.89 | 12.32 | |||||
(EBITDA - Capex) / Interest Expense | 54.5 | 30.07 | 12.4 | 11.22 | 10.61 | |||||
Total Debt / EBITDA | 0.52 | 0.87 | 1.22 | 1.3 | 1.44 | |||||
Net Debt / EBITDA | 0.38 | 0.78 | 1.07 | 1.07 | 1.32 | |||||
Total Debt / (EBITDA - Capex) | 0.54 | 0.96 | 1.4 | 1.49 | 1.67 | |||||
Net Debt / (EBITDA - Capex) | 0.4 | 0.86 | 1.22 | 1.22 | 1.53 | |||||
Growth Over Prior Year | ||||||||||
Total Revenues, 1 Yr. Growth % | 23.07 | 13.12 | 6.32 | 12.6 | 2.74 | |||||
Gross Profit, 1 Yr. Growth % | 22.5 | 13.4 | 9.58 | 14.31 | 2.02 | |||||
EBITDA, 1 Yr. Growth % | 35.91 | 14.9 | 4.63 | 12.95 | -0.3 | |||||
EBITA, 1 Yr. Growth % | 44.98 | 16.67 | 4.26 | 12.45 | -2.23 | |||||
EBIT, 1 Yr. Growth % | 50.92 | 16.6 | 4.37 | 13.3 | -1.72 | |||||
Earnings From Cont. Operations, 1 Yr. Growth % | 114.65 | 20.89 | -5.75 | 10.27 | 0.27 | |||||
Net Income, 1 Yr. Growth % | 114.65 | 20.89 | -5.75 | 10.27 | 0.27 | |||||
Normalized Net Income, 1 Yr. Growth % | 46 | 22.75 | -4.58 | 11.1 | 0.58 | |||||
Diluted EPS Before Extra, 1 Yr. Growth % | 109.55 | 28.78 | 2.61 | 17.24 | 5.11 | |||||
Accounts Receivable, 1 Yr. Growth % | 15.98 | 25.07 | 6.34 | -6.37 | -5.58 | |||||
Inventory, 1 Yr. Growth % | 53.46 | 40.79 | -1.07 | 6.24 | 10.33 | |||||
Net Property, Plant and Equip., 1 Yr. Growth % | -14.09 | 19.69 | 25.38 | 29.84 | 8.03 | |||||
Total Assets, 1 Yr. Growth % | -7.22 | 18.72 | 8.11 | 16.64 | 6.65 | |||||
Tangible Book Value, 1 Yr. Growth % | -120.63 | 335.87 | 509.73 | 11.41 | 13.11 | |||||
Common Equity, 1 Yr. Growth % | -5.25 | 2.37 | -25.28 | 2.86 | -4.1 | |||||
Cash From Operations, 1 Yr. Growth % | 4.23 | -28.81 | 66.53 | 18.11 | -15.59 | |||||
Capital Expenditures, 1 Yr. Growth % | -20.86 | 183.11 | 34.73 | 18.33 | 8.46 | |||||
Levered Free Cash Flow, 1 Yr. Growth % | -0.65 | -52.77 | 92.09 | 33.46 | -52.57 | |||||
Unlevered Free Cash Flow, 1 Yr. Growth % | -0.92 | -50.51 | 95.31 | 32.77 | -48.45 | |||||
Dividend Per Share, 1 Yr. Growth % | - | 0 | 12.5 | 11.11 | 10 | |||||
Compound Annual Growth Rate Over Two Years | ||||||||||
Total Revenues, 2 Yr. CAGR % | 3.43 | 17.99 | 9.67 | 9.41 | 7.56 | |||||
Gross Profit, 2 Yr. CAGR % | 2.59 | 17.86 | 11.47 | 11.92 | 7.99 | |||||
EBITDA, 2 Yr. CAGR % | -4.16 | 26.43 | 9.65 | 8.71 | 6.12 | |||||
EBITA, 2 Yr. CAGR % | -3.67 | 31.73 | 10.29 | 8.28 | 4.85 | |||||
EBIT, 2 Yr. CAGR % | -1.83 | 34.44 | 10.32 | 8.75 | 5.52 | |||||
Earnings From Cont. Operations, 2 Yr. CAGR % | 18.85 | 61.09 | 6.74 | 1.95 | 5.15 | |||||
Net Income, 2 Yr. CAGR % | 18.85 | 61.09 | 6.74 | 1.95 | 5.15 | |||||
Normalized Net Income, 2 Yr. CAGR % | -5.95 | 35.83 | 8.23 | 2.96 | 5.71 | |||||
Diluted EPS Before Extra, 2 Yr. CAGR % | 17.7 | 64.27 | 14.95 | 9.68 | 11.01 | |||||
Accounts Receivable, 2 Yr. CAGR % | -21.63 | 20.44 | 15.33 | 1.81 | -5.98 | |||||
Inventory, 2 Yr. CAGR % | 18.31 | 46.99 | 18.02 | 2.52 | 8.26 | |||||
Net Property, Plant and Equip., 2 Yr. CAGR % | -18.8 | 1.4 | 22.5 | 27.59 | 18.43 | |||||
Total Assets, 2 Yr. CAGR % | -7.29 | 4.95 | 13.29 | 12.29 | 11.53 | |||||
Tangible Book Value, 2 Yr. CAGR % | -79.53 | -5.18 | 415.52 | 160.63 | 12.26 | |||||
Common Equity, 2 Yr. CAGR % | 15.49 | -1.51 | -12.54 | -12.33 | -0.68 | |||||
Cash From Operations, 2 Yr. CAGR % | -4.12 | -13.86 | 8.89 | 40.24 | -0.16 | |||||
Capital Expenditures, 2 Yr. CAGR % | -25.96 | 49.69 | 95.3 | 26.26 | 13.29 | |||||
Levered Free Cash Flow, 2 Yr. CAGR % | -7.15 | -30.89 | -4.75 | 60.11 | -20.48 | |||||
Unlevered Free Cash Flow, 2 Yr. CAGR % | -7.04 | -29.37 | -1.69 | 61.03 | -17.31 | |||||
Dividend Per Share, 2 Yr. CAGR % | -5.72 | - | 6.07 | 11.8 | 10.55 | |||||
Compound Annual Growth Rate Over Three Years | ||||||||||
Total Revenues, 3 Yr. CAGR % | 0.85 | 6.56 | 13.96 | 10.64 | 7.14 | |||||
Gross Profit, 3 Yr. CAGR % | 1.67 | 6.07 | 15.03 | 12.41 | 8.52 | |||||
EBITDA, 3 Yr. CAGR % | -4.5 | 2.61 | 18.7 | 10.74 | 5.62 | |||||
EBITA, 3 Yr. CAGR % | -4.84 | 3.56 | 21.85 | 11.01 | 4.66 | |||||
EBIT, 3 Yr. CAGR % | -4.33 | 4.89 | 23.56 | 11.3 | 5.14 | |||||
Earnings From Cont. Operations, 3 Yr. CAGR % | -6.23 | 19.53 | 34.73 | 7.91 | 1.39 | |||||
Net Income, 3 Yr. CAGR % | -6.23 | 19.53 | 34.73 | 7.91 | 1.39 | |||||
Normalized Net Income, 3 Yr. CAGR % | -7.73 | 3.78 | 20.75 | 9.18 | 2.16 | |||||
Diluted EPS Before Extra, 3 Yr. CAGR % | -3.91 | 21.28 | 40.42 | 15.71 | 8.13 | |||||
Accounts Receivable, 3 Yr. CAGR % | -15.12 | -8.42 | 15.54 | 9.04 | -0.72 | |||||
Inventory, 3 Yr. CAGR % | -1.79 | 25.37 | 28.82 | 13.95 | 5.06 | |||||
Net Property, Plant and Equip., 3 Yr. CAGR % | 18.18 | -7.59 | 8.84 | 24.9 | 20.71 | |||||
Total Assets, 3 Yr. CAGR % | -1.23 | 0.68 | 6 | 14.4 | 10.38 | |||||
Tangible Book Value, 3 Yr. CAGR % | -59.24 | -43.26 | 76.33 | 209.37 | 97.33 | |||||
Common Equity, 3 Yr. CAGR % | 2.94 | 10.94 | -10.18 | -7.68 | -9.67 | |||||
Cash From Operations, 3 Yr. CAGR % | -2.03 | -13.18 | 7.31 | 11.88 | 18.41 | |||||
Capital Expenditures, 3 Yr. CAGR % | -25.88 | 15.78 | 44.52 | 65.26 | 20.03 | |||||
Levered Free Cash Flow, 3 Yr. CAGR % | 4.86 | -25.44 | -2.83 | 6.58 | 6.7 | |||||
Unlevered Free Cash Flow, 3 Yr. CAGR % | 5.26 | -24.22 | -0.86 | 8.67 | 10.12 | |||||
Dividend Per Share, 3 Yr. CAGR % | -3.85 | -3.85 | - | 7.72 | 11.2 | |||||
Compound Annual Growth Rate Over Five Years | ||||||||||
Total Revenues, 5 Yr. CAGR % | 2.9 | 3.04 | 4.29 | 7.69 | 11.36 | |||||
Gross Profit, 5 Yr. CAGR % | 3.18 | 3.54 | 5.48 | 8.37 | 12.16 | |||||
EBITDA, 5 Yr. CAGR % | -3.99 | -2.22 | 1.4 | 5.01 | 13.5 | |||||
EBITA, 5 Yr. CAGR % | -5.02 | -2.7 | 1.46 | 5.42 | 14.74 | |||||
EBIT, 5 Yr. CAGR % | -5.34 | -2.83 | 1.82 | 6.42 | 16 | |||||
Earnings From Cont. Operations, 5 Yr. CAGR % | -7.14 | -2.7 | -1.24 | 12.16 | 22.01 | |||||
Net Income, 5 Yr. CAGR % | -7.14 | -2.7 | -1.24 | 12.16 | 22.01 | |||||
Normalized Net Income, 5 Yr. CAGR % | -7.54 | -3.15 | -1.08 | 3.45 | 14.49 | |||||
Diluted EPS Before Extra, 5 Yr. CAGR % | -4.5 | 0.72 | 3.23 | 16.5 | 27.82 | |||||
Accounts Receivable, 5 Yr. CAGR % | -9.62 | -8.37 | -4.05 | -4.46 | 7.26 | |||||
Inventory, 5 Yr. CAGR % | 1.85 | 9.06 | 5.7 | 15.68 | 20.16 | |||||
Net Property, Plant and Equip., 5 Yr. CAGR % | 19.73 | 17.5 | 19.89 | 5.14 | 12.58 | |||||
Total Assets, 5 Yr. CAGR % | 4.21 | 4.78 | 4.34 | 5.17 | 8.18 | |||||
Tangible Book Value, 5 Yr. CAGR % | -38.29 | -3.73 | 12.46 | 4.41 | 47.19 | |||||
Common Equity, 5 Yr. CAGR % | 0.6 | 1.93 | -3.56 | 0.97 | -6.49 | |||||
Cash From Operations, 5 Yr. CAGR % | -0.95 | -7.66 | 2.2 | 5.18 | 4.26 | |||||
Capital Expenditures, 5 Yr. CAGR % | -18.54 | -1.2 | 9.2 | 19.86 | 31.11 | |||||
Levered Free Cash Flow, 5 Yr. CAGR % | 6.77 | -7.48 | 1.26 | 1.22 | -10.32 | |||||
Unlevered Free Cash Flow, 5 Yr. CAGR % | 7.02 | -6.39 | 2.78 | 2.44 | -7.8 | |||||
Dividend Per Share, 5 Yr. CAGR % | 12.2 | 12.2 | 0 | 2.13 | - |
- Stock Market
- Equities
- PNDORA Stock
- Financials Pandora A/S
- Financial Ratios
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition















